Please use this identifier to cite or link to this item:
Title: Profile, cost and pattern of prescriptions for polymedicated patients in Catalonia, Spain
Author: Lizano-Díez, Irene
Modamio Charles, Pilar
López Calahorra, Pilar
Fernández Lastra, Cecilia
Gilabert-Perramon, A.
Segú Tolsà, Josep Lluís
Mariño Hernández, Eduardo L.
Keywords: Farmacoepidemiologia
Prescripció de medicaments
Malalts crònics
Atenció primària
Pharmaceutical economics
Drug prescribing
Chronically ill
Primary health care
Issue Date: 12-Dec-2013
Publisher: BMJ Publishing Group
Abstract: OBJECTIVES: Polypharmacy is one of the main management issues in public health policies because of its financial impact and the increasing number of people involved. The polymedicated population according to their demographic and therapeutic profile and the cost for the public healthcare system were characterised. DESIGN: Cross-sectional study. SETTING: Primary healthcare in Barcelona Health Region, Catalonia, Spain (5 105 551 inhabitants registered). PARTICIPANTS: All insured polymedicated patients. Polymedicated patients were those with a consumption of ≥16 drugs/month. MAIN OUTCOMES MEASURES: The study variables were related to age, gender and medication intake obtained from the 2008 census and records of prescriptions dispensed in pharmacies and charged to the public health system. RESULTS: There were 36 880 polymedicated patients (women: 64.2%; average age: 74.5±10.9 years). The total number of prescriptions billed in 2008 was 2 266 830 (2 272 920 total package units). The most polymedicated group (up to 40% of the total prescriptions) was patients between 75 and 84 years old. The average number of prescriptions billed monthly per patient was 32±2, with an average cost of 452.7±27.5. The total cost of those prescriptions corresponded to 2% of the drug expenditure in Catalonia. The groups N, C, A, R and M represented 71.4% of the total number of drug package units dispensed to polymedicated patients. Great variability was found between the medication profiles of men and women, and between age groups; greater discrepancies were found in paediatric patients (5-14 years) and the elderly (≥65 years). CONCLUSIONS: This study provides essential information to take steps towards rational drug use and a structured approach in the polymedicated population in primary healthcare.
Note: Reproducció del document publicat a:
It is part of: BMJ Open, 2013, vol. 3, num. 12, p. e003963
Related resource:
ISSN: 2044-6055
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
633172.pdf556.85 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons